Therapy of insufficiency of the great saphenous vein with catheter-assisted micro-foam therapy without heparin;Therapie der stammvarikose der vena saphena magna mittels kathetergestützter mikroschaum-sklerosierung ohne heparinprophylaxe

Phlebologie

Volumn 37, Issue 4, 2008, Pages 198-203

  Reich Schupke, Stefanie ^a   Altmeyer, P ^a   Stucker M ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

Catheter assisted sclerotherapy; Endoluminal therapy; Foam sclerotherapy; Trunk varicosis

Indexed keywords

HEPARIN;

ARTICLE; CATHETER; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HUMAN; RISK ASSESSMENT; SAPHENOUS VEIN; SCLEROTHERAPY; THROMBOEMBOLISM; ULTRASOUND; VEIN INSUFFICIENCY;

EID: 53549108026     PISSN: 0939978X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1622231     Document Type: Article

References (31)

1. Bergan J. Sclerotherapy: A truly minimally invasive technique. Perspect Vasc Surg Endovasc Ther 2008; 20: 70-72.
2. Bidwai A, Beresford T, Dialynas M, Prionidis J, Panayiotopoulos Y, Browne TF. Balloon control of the saphenofemorl junction during foam sclerotherapy: Proposed innovation. J Vasc Surg 2007; 46: 145-147.
3. Böhler K. Neue Techniken zur Therapie der Varikose. Z Gefäßmed 2005; 3: 9-12.
4. Brandjes DPM, Büller HR, Heijboer H, Huisman MV, de Rijk M, Jagt H, ten Cate JW. Randomized trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997; 349: 759-762.
5. nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany. VASA 2008; S71: 3-29.
6. Brodersen JP, Geismar U. Catheter-assisted vein sclerotherapy: a new approach for sclerotherapy of the greater saphenous vein with a double-lumen balloon catheter. Dermatol Surg 2007; 33: 469-475.
7. Cabrera J, Cabrera J Jr, Garcia-Olmedo MA. Treatment of varicose long saphenous veins with sclerosant in microfoam form: long-term outcomes. Phlebology 2000; 15: 19-23.
8. Colderidge-Smith P. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg 2006; 32: 577-583.
9. DGP, DGA. Interdisziplinäre S2-Leitlinie Diagnostik und Therapie der Bein- und Beckenvenenthrombose und der Lungenembolie. Phlebologie 2005; 34: 47-64.
10. Encke A, Haas S, Krauspe R, Riess H, Stürmer KM, Kopp I et al. Stationäre und ambulante Thrombembolieprophylaxe in der Chirurgie und der perioperativen Medizin. Phlebologie 2003; 32: 164-169.
11. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thrombembolism: American College of CHest Physicians Evidence-Based Clinical Practise Guidelines. Chest 2008; 133: 381S-453S.
12. Greinacher A, Lubenow N, Hinz P, Ekkernkamp A. Heparininduzierte Thrombozytopenie. Dtsch Ärztebl 2003; 100A: 2220-2229.
13. Guex JJ, Allaert FA, Gillet JL, Chleir F. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12173 sclerotherapy sessions. Dermatol Surg 2005; 31: 123-128.
14. Guex JJ. Foam Sclerotherapy: An overview of use for primary venous insufficiency. Semin Vasc Surg 2005; 18: 25-29.
15. Hahn M, Schulz T, Jünger M. Sonographically guided, transcatheter foam sclerotherapy of the great saphenous vein. Phlebologie 2007; 36: 309-312.
16. Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, Mako S, Allaert FA. Evaluation of the efficiency of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 2003; 29: 1170-1175.
17. Ikeda M, Kambayashi J, Iwamoto S, Shinoki N, Nakamura T, Okahara K, Fujitani K, Shibuya T, Kawasaki T, Monden M. Haemostasis activation during sclerotherapy of lower extremity varices. Thromb Res 1996; 82: 87-95.
18. Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C. Systematic review of foam sclerotherapy for varicose veins. Br J Surg 2007; 94: 925-936.
19. Kölbel T, Hinchliffe RJ, Lindblad B. Catheter-directed foam sclerotherapy of axial saphenous reflux: early results. Phlebology 2007; 22: 219-222.
20. Kreussler. Aethoxysklerol-Fachinformation der Herstellerfabrik, Chemische Fabrik Kreussler & Co GmbH 1996.
21. Meyers KA, Jolley D, Clough A, Kirwan J. Outcome of ultrasound-guided sclerotherapy for varicose veins: Medium-term results assessed by ultrasound surveillance. Eur Ja Vasc Endovasc Surg 2007; 33: 116-121.
22. Min RJ, Navarro L. Transcatheter duplex ultrasound-guided sclerotherapy for treatment of greater saphenous vein reflux: preliminary report. Dermatol Surg 2000; 26: 410-414.
23. Noppeney T, Kluess HG, Gerlach H et al. Leitlinien zur Diagnostik und Therapie desr Krampfadererkrankung. Gefäßchirurgie 2004; 9: 290-308.
24. Nuellen H, Noppeney T. Thromboseprophylaxe in der Varizenchirurgie. Gefäßchirurgie 2006; 11: 117-120.
25. Parsi K, Exner T, Connor DE, Ma DDF, Joseph JE. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles. Eur J Vasc Endovasc Surg 2007; 34: 731-740.
26. Proebstle TM. Endovenöse Lasertherapie der Variköse. Phlebologie 2003; 32: 131-137.
27. Rabe E, Pannier F, Gerlach H, Breu FX, Guggenbichler S, Wollmann C. Leitlinien: Sklerosierungsbehandlung der Varikose. Phlebologie 2008; 37: 27-34.
28. Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001; 27: 58-60.
29. Wildenhues B. Endovenöse kathetergestützte Schaumsklerosierung. Phlebologie 2005; 34: 165-170.
30. Wildenhues B. Schaumsklerosierung - eine wiederentdeckte Therapieoption in der Behandlung der Varikosis. Vasomed 2006; 18: 106-108.
31. Wright D, Gobin JP, Bradburry AW, Coleridge-Smith P, Spoelstra H, Berridge D, Wittens CHA, Sommer A, Nelzen O, Chanter D. Varisolve® polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial. Phlebology 2006; 21: 180-190.